DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination (Q37756125)

22 August 2017

1 reference

title

DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination (English)

1 reference

22 August 2017

1

Sohita Dhillon

1 reference

PubMed ID

20481658

22 August 2017

language of work or name

1 reference

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

70

1 reference

22 August 2017

8

1 reference

22 August 2017

1021-1058

1 reference

https://scigraph.springernature.com/pub.10.2165/11204830-000000000-00000

22 August 2017

0 references

cites work

Persistence of antibodies in children primed with two different hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type B vaccines and evaluation of booster vaccination

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11204830-000000000-00000

Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11204830-000000000-00000

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11204830-000000000-00000

Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.

21 January 2018

1 reference

12 December 2020

Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine).

1 reference

12 December 2020

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates

1 reference

12 December 2020

Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis

1 reference

12 December 2020

The use of combination vaccines has improved timeliness of vaccination in children

1 reference

12 December 2020

Four and One-Half-Year Follow-up of the Effectiveness of Diphtheria-Tetanus Toxoids-Acellular Pertussis/Haemophilus influenzae Type b and Diphtheria-Tetanus Toxoids-Acellular Pertussis-Inactivated Poliovirus/H. influenzae Type b Combination Vaccines

1 reference

12 December 2020

Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants

1 reference

12 December 2020

Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany

1 reference

12 December 2020

Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV combination vaccine Co-administered with a hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age

1 reference

12 December 2020

Considerations for implementing a new combination vaccine into managed care

1 reference

12 December 2020

Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate va

1 reference

12 December 2020

Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely

1 reference

12 December 2020

Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule

1 reference

12 December 2020

Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate v

1 reference

12 December 2020

Global Advisory Committee on Vaccine Safety, 2-3 December 2004

1 reference

12 December 2020

WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record.

1 reference

12 December 2020

Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persi

1 reference

12 December 2020

Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age

1 reference

12 December 2020

Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections

1 reference

12 December 2020

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines

1 reference

12 December 2020

Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered

1 reference

12 December 2020

Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid

1 reference

12 December 2020

Comment on B. Zinka et al., Unexplained cases of sudden infant death shortly after hexavalent vaccination

1 reference

12 December 2020

Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine

1 reference

12 December 2020

Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants

1 reference

12 December 2020

Efficacy of acellular pertussis vaccine in early childhood after household exposure.

1 reference

12 December 2020

Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separately

1 reference

12 December 2020

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

1 reference

12 December 2020

Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination

1 reference

12 December 2020

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine

1 reference

12 December 2020

Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine

1 reference

12 December 2020

Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure

1 reference

12 December 2020

Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of age.

1 reference

12 December 2020

Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue

1 reference

12 December 2020

Global Advisory Committee on Vaccine Safety, 9-10 June 2005

1 reference

12 December 2020

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

12 December 2020

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.

1 reference

12 December 2020

Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine

1 reference

12 December 2020

Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life

1 reference

12 December 2020

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

1 reference

12 December 2020

Immunological persistence in 4-6 and 7-9 year olds previously vaccinated in infancy with hexavalent DTPa-HBV-IPV/Hib.

1 reference

12 December 2020

Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP)

1 reference

12 December 2020

Antibody persistence after primary vaccination with a hexavalent DTPa-HBV-IPV/HiB vaccine coadministered with a meningococcal C-CRM197 vaccine and response to a DTPa-IPV/HiB booster at 18 months of age.

1 reference

12 December 2020

Sudden and unexpected deaths after the administration of hexavalent vaccines (diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, Haemophilius influenzae type b): is there a signal?

1 reference

12 December 2020

Booster vaccinations: can immunologic memory outpace disease pathogenesis?

1 reference

12 December 2020

10.2165/11204830-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20481658

Dimensions Publication ID

22 August 2017

0 references

1 reference

PubMed ID

20481658